Chromium picolinate
Trace mineral with an EU-authorised claim for maintenance of normal blood glucose levels; trial results in type 2 diabetes are inconsistent.
- Evidence
- Preliminary evidenceGRADE certainty: Low
- Typical dose
- 200–1,000 µg/day
- Time to effect
- Not established
- Safety
- Has documented cautions
Evidence ratings summarise published research on Chromium picolinate in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Chromium picolinate
Interactions
Taking any medication?
Check Chromium picolinate against it.
Why
Chromium is a trace mineral previously thought to be essential for insulin signalling. A meta-analysis of 15 trials (Althuis 2002, n=618) found no effect of chromium on glucose or insulin in people without diabetes, and inconclusive results in diabetes. Individual trials in type 2 diabetes conflict: one small RCT of chromium picolinate reported lower HbA1c, while a trial of chromium yeast found none. The EU authorised claim is that chromium contributes to the maintenance of normal blood glucose levels.
How it works
Chromium proposed to modulate insulin receptor signalling via chromodulin (LMWCr) interaction with the insulin receptor, though whether chromium is essential remains contested. Picolinate form has better intestinal absorption than inorganic chromium salts.
Expected onset · Not established; trial results are inconsistent
How to take
Dosage
200–1,000 µg/day. Most trials use 200–600 µg/day.
Timing
Once daily with food
On the label
Chromium picolinate (better-absorbed form), stated micrograms of elemental chromium per dose, not picolinate salt weight.
Studied in
Adults curious about chromium's role in normal blood glucose, with realistic expectations given inconsistent trial results.
Safety
Evidence
Althuis 2002 Am J Clin Nutr meta-analysis (15 trials, n=618): no effect of chromium on glucose or insulin in people without diabetes, and inconclusive results in diabetes. Martin 2006 Diabetes Care RCT (n=37) reported lower HbA1c with chromium picolinate in type 2 diabetes; Kleefstra 2007 Diabetes Care RCT found none with chromium yeast. EU authorised claim: "Chromium contributes to the maintenance of normal blood glucose levels."
GRADE certainty: Low — rated by Healicus using the GRADE method
Preliminary, RCTs exist in non-tier-1 journals but are small or short-duration. No Cochrane review, EMA monograph or EFSA-authorised claim covers the indication.
- EU authorised health claim: “Chromium contributes to the maintenance of normal blood glucose levels.”
- EU authorised health claim: “Chromium contributes to normal macronutrient metabolism.”
- Martin J et al., Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes, Diabetes Care 2006
- Lee NA, Reasner CA, Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM, Diabetes Care 1994
- Kleefstra N et al., Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial, Diabetes Care 2007
- Althuis MD et al., Glucose and insulin responses to dietary chromium supplements: a meta-analysis, Am J Clin Nutr 2002
- Brandimonte-Hernández M et al., Effects of Food Bioactive Compounds on Oxidative Stress and the Antioxidant Defense System in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Nutr Rev 2026
Questions people ask
Does Chromium picolinate work?
Althuis 2002 Am J Clin Nutr meta-analysis (15 trials, n=618): no effect of chromium on glucose or insulin in people without diabetes, and inconclusive results in diabetes. Martin 2006 Diabetes Care RCT (n=37) reported lower HbA1c with chromium picolinate in type 2 diabetes; Kleefstra 2007 Diabetes Care RCT found none with chromium yeast. EU authorised claim: "Chromium contributes to the maintenance of normal blood glucose levels." Certainty of the evidence: Low, rated by Healicus using the GRADE method.
How is Chromium picolinate taken?
200–1,000 µg/day. Most trials use 200–600 µg/day. Timing: Once daily with food. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Case reports of nephrotoxicity at very high doses (>1,000 µg/day). May potentiate hypoglycaemia with insulin and sulphonylureas. Theoretical mood effect (small RCT signal for atypical depression, McLeod 1999). Pregnancy and breastfeeding data limited. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: EU authorised health claim: “Chromium contributes to the maintenance of normal blood glucose levels.”; EU authorised health claim: “Chromium contributes to normal macronutrient metabolism.”; Martin J et al., Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes, Diabetes Care 2006; Lee NA, Reasner CA, Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM, Diabetes Care 1994; Kleefstra N et al., Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial, Diabetes Care 2007; Althuis MD et al., Glucose and insulin responses to dietary chromium supplements: a meta-analysis, Am J Clin Nutr 2002; Brandimonte-Hernández M et al., Effects of Food Bioactive Compounds on Oxidative Stress and the Antioxidant Defense System in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Nutr Rev 2026.
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.